EYEG Shares Outstanding History
Below is a table of the EYEG shares outstanding history going back to 3/27/2015:

Date EYEG Shares Outstanding
3/27/2015422239
5/14/2015431806
5/15/2015431806
7/29/2015484928
8/12/2015510238
11/6/2015510310
3/28/2016556430
5/13/2016556430
8/10/2016596792
11/1/2016639059
2/17/2017682326
5/3/2017725208
8/2/20171.15M
11/10/20171.15M
2/28/20181.15M
5/9/20182.78M
8/1/20182.90M
11/9/20182.90M
2/27/20192.92M
5/6/20193.04M
8/6/20193.05M
8/30/20193.05M
11/5/20193.64M
3/2/20204.63M
3/31/20204.63M
8/4/20204.63M
11/6/20204.63M
3/23/20217.10M
5/10/20217.10M
8/11/202112.62M

Also see: EYEG Market Cap History
EYEG YTD Return
EYEG Historical Shares Outstanding:
+70.31% CAGR
EYEG Historical Shares Outstanding: +70.31% CAGR

Mouse over chart for data details
3/27/2015 ...8/11/2021
Eyegate Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing products for treating disorders of the eye. Co.'s key product in clinical development is the EyeGate Ocular Bandage Gel, a topically applied eye drop formulation of modified hyaluronic acid (HA). HA is a naturally occurring polymer that is used in various physiological processes, including wound healing, hydration, tissue homeostasis, and joint lubrication. Co. modifies the HA through chemical cross-linking, which allows it to adhere to the ocular surface providing protection and lubrication for the treatment of corneal wounds, defects, and epitheliopathies. We show 30 historical shares outstanding datapoints in our coverage of EYEG's shares outstanding history.

Understanding the changing numbers of EYEG shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EYEG versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EYEG by allowing them to research EYEG shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree EYEG Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Eyegate Pharmaceuticals (EYEG) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EYEN Shares Outstanding History
EYES Shares Outstanding History
EYPT Shares Outstanding History
FATE Shares Outstanding History
FBIO Shares Outstanding History
FBRX Shares Outstanding History
FCRE Shares Outstanding History
FCSC Shares Outstanding History
FDMT Shares Outstanding History
FEMY Shares Outstanding History
More Healthcare companies »

 

EYEG Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.